{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["analytical quality by design (AQbD)", "analytical tools", "lifecycle management", "medicinal plants", "method operable design region (MODR)", "natural products"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36365413", "DateRevised": {"Year": "2022", "Month": "11", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "02"}], "Language": ["eng"], "ELocationID": ["2960", "10.3390/plants11212960"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "21", "PubDate": {"Year": "2022", "Month": "Nov", "Day": "02"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Analytical Quality by Design (AQbD) Approach to the Development of Analytical Procedures for Medicinal Plants.", "Abstract": {"AbstractText": ["Scientific regulatory systems with suitable analytical methods for monitoring quality, safety, and efficacy are essential in medicinal plant drug discovery. There have been only few attempts to adopt the analytical quality by design (AQbD) strategy in medicinal plants analysis over the last few years. AQbD is a holistic method and development approach that understands analytical procedure, from risk assessment to lifecycle management. The enhanced AQbD approach reduces the time and effort necessary to develop reliable analytical methods, leads to flexible change control through the method operable design region (MODR), and lowers the out-of-specification (OOS) results. However, it is difficult to follow all the AQbD workflow steps in the field of medicinal plants analysis, such as defining the analytical target profiles (ATPs), identifying critical analytical procedure parameters (CAPPs), among others, because the complexity of chemical and biological properties in medicinal plants acts as a barrier. In this review, various applications of AQbD to medicinal plant analytical procedures are discussed. Unlike the analysis of a single compound, medicinal plant analysis is characterized by analyzing multiple components contained in biological materials, so it will be summarized by focusing on the following points: Analytical methods showing correlations within analysis parameters for the specific medicinal plant analysis, plant raw material diversity, one or more analysis targets defined for multiple phytochemicals, key analysis attributes, and analysis control strategies. In addition, the opportunities available through the use of design-based quality management techniques and the challenges that coexist are also discussed."]}, "AuthorList": [{"Identifier": ["0000-0002-7072-2602"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Korea."}], "LastName": "Park", "ForeName": "Geonha", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacognosy, College of Pharmacy, Kyung Hee University, Seoul 02447, Korea."}], "LastName": "Kim", "ForeName": "Min Kyoung", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Korea."}], "LastName": "Go", "ForeName": "Seung Hyeon", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Korea."}], "LastName": "Choi", "ForeName": "Minsik", "Initials": "M"}, {"Identifier": ["0000-0001-5865-9228"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Korea."}, {"Identifier": [], "Affiliation": "Department of Biomedical and Pharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Korea."}, {"Identifier": [], "Affiliation": "Department of Integrated Drug Development and Natural Products, Graduate School, Kyung Hee University, Seoul 02447, Korea."}], "LastName": "Jang", "ForeName": "Young Pyo", "Initials": "YP"}], "GrantList": [{"GrantID": "NRF-2020R1A2C1101885", "Agency": "National Research Foundation of Korea", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wu C., Lee S.-L., Taylor C., Li J., Chan Y.-M., Agarwal R., Temple R., Throckmorton D., Tyner K. Scientific and regulatory approach to botanical drug development: A US FDA perspective. J. Nat. Prod. 2020;83:552\u2013562. doi: 10.1021/acs.jnatprod.9b00949.", "ArticleIdList": ["10.1021/acs.jnatprod.9b00949", "31977211"]}, {"Citation": "Ahn K. The worldwide trend of using botanical drugs and strategies for developing global drugs. BMB Rep. 2017;50:111\u2013116. doi: 10.5483/BMBRep.2017.50.3.221.", "ArticleIdList": ["10.5483/BMBRep.2017.50.3.221", "PMC5422022", "27998396"]}, {"Citation": "Dushenkov V., Graf B.L., Lila M.A. Botanical therapeutics in the modern world. CUNY Acad. Works. 2016;43:50\u201354."}, {"Citation": "Atanasov A.G., Zotchev S.B., Dirsch V.M., Supuran C.T. Natural products in drug discovery: Advances and opportunities. Nat. Rev. Drug Discov. 2021;20:200\u2013216. doi: 10.1038/s41573-020-00114-z.", "ArticleIdList": ["10.1038/s41573-020-00114-z", "PMC7841765", "33510482"]}, {"Citation": "Azwanida N. A review on the extraction methods use in medicinal plants, principle, strength and limitation. Med. Aromat Plants. 2015;4:2167-0412."}, {"Citation": "Zhang T., Bai G., Han Y., Xu J., Gong S., Li Y., Zhang H., Liu C. The method of quality marker research and quality evaluation of traditional Chinese medicine based on drug properties and effect characteristics. Phytomedicine. 2018;44:204\u2013211. doi: 10.1016/j.phymed.2018.02.009.", "ArticleIdList": ["10.1016/j.phymed.2018.02.009", "29551645"]}, {"Citation": "Sousa L.V.E., Gon\u00e7alves R., Menezes J.C., Ramos A. Analytical method lifecycle management in pharmaceutical industry: A review. AAPS PharmSciTech. 2021;22:128. doi: 10.1208/s12249-021-01960-9.", "ArticleIdList": ["10.1208/s12249-021-01960-9", "33835304"]}, {"Citation": "Deidda R., Orlandini S., Hubert P., Hubert C. Risk-based approach for method development in pharmaceutical quality control context: A critical review. J. Pharm. Biomed. Anal. 2018;161:110\u2013121. doi: 10.1016/j.jpba.2018.07.050.", "ArticleIdList": ["10.1016/j.jpba.2018.07.050", "30145448"]}, {"Citation": "Jayagopal B., Shivashankar M. Analytical quality by design\u2014A legitimate paradigm for pharmaceutical analytical method development and validation.  [(accessed on 27 September 2022)];Mech. Mater. Sci. Eng. J. 2017 9 Available online:  https://hal.archives-ouvertes.fr/hal-01504765/document."}, {"Citation": "Rignall A. Analytical Procedure Lifecycle Management: Current Status and Opportunities. Pharm. Technol. 2018;42:18\u201323."}, {"Citation": "European Medicines Agency  ICH Guideline Q9(R1) on Quality Risk Management. Step 2b, Amsterdam, The Netherlands. 2021.  [(accessed on 16 December 2021)].  Available online:  https://www.ema.europa.eu/en/documents/scientific-guideline/draft-international-conference-harmonisation-technical-requirements-registration-pharmaceuticals_en-1.pdf."}, {"Citation": "Ramalinagm P., Shakir Basha S., Bhaddraya K., Beg S. Handbook of Analytical Quality by Design. Elsevier; Amsterdam, The Netherlands: 2021. Risk assessment and design space consideration in analytical quality by design; pp. 167\u2013189."}, {"Citation": "United States Pharmacopeia . General Chapter, <1220> Analytical Procedure Lifecycle USP-NF. United States Pharmacopeia; Rockville, MD, USA: 2022.", "ArticleIdList": ["10.31003/USPNF_M10975_02_01"]}, {"Citation": "Elder D., Borman P. Improving Analytical Method Reliability Across the Entire Product Lifecycle Using QbD Approaches. Pharmaceutical Outsoursing. 2013.  [(accessed on 7 August 2013)].  Available online:  https://www.pharmoutsourcing.com/Featured-Articles/142484-Improving-Analytical-Method-Reliability-Across-the-Entire-Product-Lifecycle-Using-QbD-Approaches/"}, {"Citation": "Hubert C., Lebrun P., Houari S., Ziemons E., Rozet E., Hubert P. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: A case of a learning process. J. Pharm. Biomed. Anal. 2014;88:401\u2013409.", "ArticleIdList": ["24176744"]}, {"Citation": "Tome T., \u017d igart N., \u010casar Z., Obreza A. Development and optimization of liquid chromatography analytical methods by using AQbD principles: Overview and recent advances. Org. Process Res. Dev. 2019;23:1784\u20131802. doi: 10.1021/acs.oprd.9b00238.", "ArticleIdList": ["10.1021/acs.oprd.9b00238"]}, {"Citation": "Das P., Maity A. Analytical quality by design (AQbD): A new horizon for robust analytics in pharmaceutical process and automation. Int. J. Pharm. Drug Anal. 2017;5:324\u2013337."}, {"Citation": "European Medicines Agency  ICH Guideline Q14 on Analytical Procedure Development Step 2b. Amsterdam, The Netherlands. 2022.  [(accessed on 31 March 2022)].  Available online:  https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-q14-analytical-procedure-development-step-2b_en.pdf."}, {"Citation": "Mishra V., Thakur S., Patil A., Shukla A. Quality by design (QbD) approaches in current pharmaceutical set-up. Expert Opin. Drug Deliv. 2018;15:737\u2013758.", "ArticleIdList": ["30044646"]}, {"Citation": "Jain S. Quality by design (QBD): A comprehensive understanding of implementation and challenges in pharmaceuticals development. Int. J. Pharm. Pharm. Sci. 2014;6:29\u201335."}, {"Citation": "Holm P., Alles\u00f8 M., Bryder M.C., Holm R. ICH Quality Guidelines: An Implementation Guide. John Wiley & Sons, Inc.; Hoboken, NJ, USA: 2017. Q8 (R2) Pharmaceutical Development; pp. 535\u2013577."}, {"Citation": "Zhang L., Mao S. Application of quality by design in the current drug development. Asian J. Pharm. Sci. 2017;12:1\u20138. doi: 10.1016/j.ajps.2016.07.006.", "ArticleIdList": ["10.1016/j.ajps.2016.07.006", "PMC7032183", "32104308"]}, {"Citation": "Singh B., Khurana R.K., Kaur R., Beg S. Quality by design (QbD) paradigms for robust analytical method development. Pharma Rev. 2016;14:61\u201366."}, {"Citation": "Borman P., Campa C., Delpierre G., Hook E., Jackson P., Kelley W., Protz M., Vandeputte O. Selection of Analytical Technology and Development of Analytical Procedures Using the Analytical Target Profile. Anal. Chem. 2022;94:559\u2013570. doi: 10.1021/acs.analchem.1c03854.", "ArticleIdList": ["10.1021/acs.analchem.1c03854", "34928590"]}, {"Citation": "Prajapati P.B., Jayswal K., Shah S.A. Application of quality risk assessment and DoE-based enhanced analytical quality by design approach to development of chromatography method for estimation of combined pharmaceutical dosage form of five drugs. J. Chromatogr. Sci. 2021;59:714\u2013729. doi: 10.1093/chromsci/bmaa118.", "ArticleIdList": ["10.1093/chromsci/bmaa118", "33352579"]}, {"Citation": "Little T. Design of experiments for analytical method development and validation. BioPharm Int. 2014;27:40\u201345."}, {"Citation": "Raman N., Mallu U.R., Bapatu H.R. Analytical quality by design approach to test method development and validation in drug substance manufacturing. J. Chem. 2015;2015:435129. doi: 10.1155/2015/435129.", "ArticleIdList": ["10.1155/2015/435129"]}, {"Citation": "Rozet E., Lebrun P., Hubert P., Debrus B., Boulanger B. Design spaces for analytical methods. TrAC Trends Anal. Chem. 2013;42:157\u2013167. doi: 10.1016/j.trac.2012.09.007.", "ArticleIdList": ["10.1016/j.trac.2012.09.007"]}, {"Citation": "European Medicines Agency  ICH Guideline Q10 on Pharmaceutical Quality System Step 5, Amsterdam, The Netherlands. 2015.  [(accessed on 1 September 2015)].  Available online:  https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human_en.pdf."}, {"Citation": "Parr M.K., Schmidt A.H. Life cycle management of analytical methods. J. Pharm. Biomed. Anal. 2018;147:506\u2013517. doi: 10.1016/j.jpba.2017.06.020.", "ArticleIdList": ["10.1016/j.jpba.2017.06.020", "28666555"]}, {"Citation": "Jackson P., Borman P., Campa C., Chatfield M., Godfrey M., Hamilton P., Hoyer W., Norelli F., Orr R., Schofield T. Using the analytical target profile to drive the analytical method lifecycle. Anal. Chem. 2019;91:2577\u20132585. doi: 10.1021/acs.analchem.8b04596.", "ArticleIdList": ["10.1021/acs.analchem.8b04596", "30624912"]}, {"Citation": "Dispas A., Avohou H.T., Lebrun P., Hubert P., Hubert C. \u2018Quality by Design\u2019 approach for the analysis of impurities in pharmaceutical drug products and drug substances. TrAC Trends Anal. Chem. 2018;101:24\u201333. doi: 10.1016/j.trac.2017.10.028.", "ArticleIdList": ["10.1016/j.trac.2017.10.028"]}, {"Citation": "Weitzel J., Forbes R.A., Snee R.D. The Use of the Analytical Target Profile in the Lifecycle of an Analytical Procedure. J. Valid. Technol. 2015"}, {"Citation": "Kim M.K., Park S.C., Park G., Choi E., Ji Y., Jang Y.P. Analytical quality by design methodology for botanical raw material analysis: A case study of flavonoids in Genkwa Flos. Sci. Rep. 2021;11:11936.", "ArticleIdList": ["PMC8185112", "34099770"]}, {"Citation": "Zhang H., Wang J., Chen Y., Shen X., Jiang H., Gong X., Yan j. Establishing the chromatographic fingerprint of traditional Chinese medicine standard decoction based on quality by design approach: A case study of Licorice. J. Sep. Sci. 2019;42:1144\u20131154.", "ArticleIdList": ["30624023"]}, {"Citation": "Kim M.K., Park G., Hong S.-P., Jang Y.P. Analytical Quality by Design Methodology Approach for Simultaneous Quantitation of Paeoniflorin and Decursin in Herbal Medicine by RP-HPLC Analysis. Nat. Prod. Sci. 2021;27:264\u2013273."}, {"Citation": "Tiwari R., Kumar A., Solanki P., Dhobi M., Sundaresan V., Kalaiselvan V., Raghuvanshi R.S. Analytical quality-by-design (AQbD) guided development of a robust HPLC method for the quantification of plumbagin from Plumbago species. J. Liq. Chromatogr. Relat. Technol. 2021;44:529\u2013537."}, {"Citation": "Dai S., Xu B., Zhang Y., Sun F., Li J., Shi X., Qiao Y. Robust design space development for HPLC analysis of five chemical components in Panax notoginseng saponins. J. Liq. Chromatogr. Relat. Technol. 2016;39:504\u2013512."}, {"Citation": "Gong X., Zhang Y., Chen H., Chen T., Pan J., Wang X., Qu H. Development of an analytical method by defining a design space: A case study of saponin determination for Panax notoginseng extracts. Anal. Methods. 2016;8:2282\u20132289."}, {"Citation": "Gaonkar V.P., Hullatti K. Quality assessment and RP-HPLC method development for estimation of curcuminoids in Curcuma longa: A Quality by Design approach. J. Liq. Chromatogr. Relat. Technol. 2021;44:95\u2013102."}, {"Citation": "Zhang S., Wu L., Wang X., Gong X., Qu H. Development of an HPLC\u2013MS method for the determination of four terpene trilactones in Ginkgo biloba leaf extract via quality by design. Biomed. Chromatogr. 2021;35:e5170.", "ArticleIdList": ["33982313"]}, {"Citation": "Ancillotti C., Orlandini S., Ciofi L., Pasquini B., Caprini C., Droandi C., Furlanetto S., Bubba M.D. Quality by design compliant strategy for the development of a liquid chromatography\u2013tandem mass spectrometry method for the determination of selected polyphenols in Diospyros kaki. J. Chromatogr. A. 2018;1569:79\u201390.", "ArticleIdList": ["30029776"]}, {"Citation": "Deidda R., Schelling C., Roussel J.-M., Dispas A., Bleye C.D., Ziemons E., Hubert P., Veuthey J.-L. The analysis of cannabinoids in cannabis samples by supercritical fluid chromatography and ultra-high-performance liquid chromatography: A comparison study. Anal. Sci. Adv. 2021;2:2\u201314."}, {"Citation": "Silva P., Silva C.L., Perestrelo R., Nunes F.M., C\u00e2mara J.S. Application of quality-by-design approach in the analytical method development for quantification of sugars in sugarcane honey by reversed-phase liquid chromatography. Food Anal. Methods. 2020;13:1634\u20131649."}, {"Citation": "Shao J., Cao W., Qu H., Pan J., Gong X. A novel quality by design approach for developing an HPLC method to analyze herbal extracts: A case study of sugar content analysis. PLoS ONE. 2018;13:e0198515.", "ArticleIdList": ["PMC5993237", "29883452"]}, {"Citation": "Silva P., Silva C.L., Perestrelo R., Nunes F.M., C\u00e2mara J.S. A useful strategy based on chromatographic data combined with quality-by-design approach for food analysis applications. The case study of furanic derivatives in sugarcane honey. J. Chromatogr. A. 2017;1520:117\u2013126.", "ArticleIdList": ["28916394"]}, {"Citation": "Wang L., Qu H. Development and optimization of SPE-HPLC-UV/ELSD for simultaneous determination of nine bioactive components in Shenqi Fuzheng Injection based on Quality by Design principles. Anal. Bioanal. Chem. 2016;408:2133\u20132145.", "ArticleIdList": ["26825340"]}, {"Citation": "Deidda R., Avohou H.T., Baronti R., Davolio P.L., Pasquini B., Bubba M.D., Hubert C., Hubert P., Orlandini S., Furlanetto S. Analytical quality by design: Development and control strategy for a LC method to evaluate the cannabinoids content in cannabis olive oil extracts. J. Pharm. Biomed. Anal. 2019;166:326\u2013335.", "ArticleIdList": ["30685656"]}, {"Citation": "Dai S.-Y., Xu B., Zhang Y., Li J., Sun F., Shi X., Qiao Y. Establishment and reliability evaluation of the design space for HPLC analysis of six alkaloids in Coptis chinensis (Huanglian) using Bayesian approach. Chin. J. Nat. Med. 2016;14:697\u2013708.", "ArticleIdList": ["27667516"]}, {"Citation": "European Medicines Agency  ICH Guideline Q11 on Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities) Amsterdam, The Netherlands. 2012.  [(accessed on 1 November 2012)].  Available online:  https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-q11-development-manufacture-drug-substances-chemical-entities-biotechnological/biological-entities_en.pdf."}, {"Citation": "Van Leeuwen J.F., Nauta M.J., Kaste D.D., Odekerken-Rombouts Y.M.C.F., Oldenhof M.T., Vredenbregt M.J., Barends D.M. Risk analysis by FMEA as an element of analytical validation. J. Pharm. Biomed. Anal. 2009;50:1085\u20131087.", "ArticleIdList": ["19640668"]}, {"Citation": "Almeida J., Bezerra M., Markl D., Berghaus A., Borman P., Schlindwein W. Development and Validation of an in-line API Quantification Method Using AQbD Principles Based on UV-Vis Spectroscopy to Monitor and Optimise Continuous Hot Melt Extrusion Process. Pharmaceutics. 2020;12:150. doi: 10.3390/pharmaceutics12020150.", "ArticleIdList": ["10.3390/pharmaceutics12020150", "PMC7076712", "32059445"]}, {"Citation": "Dejaegher B., Heyden Y.V. Experimental designs and their recent advances in set-up, data interpretation, and analytical applications. J. Pharm. Biomed. Anal. 2011;56:141\u2013158.", "ArticleIdList": ["21632194"]}, {"Citation": "Fukuda I.M., Pinto C.F.F., Moreira C.D.S., Saviano A.M., Louren\u00e7o F.R.L. Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD) Braz. J. Pharm. Sci. 2018;54 doi: 10.1590/s2175-97902018000001006.", "ArticleIdList": ["10.1590/s2175-97902018000001006"]}, {"Citation": "Lundstedt T., Seifert E., Abramo L., Thelin B., Nystr\u00f6m \u00c5., Pettersen J., Bergman R. Experimental design and optimization. Chemom. Intell. Lab. Syst. 1998;42:3\u201340."}, {"Citation": "Singh B., Kumar R., Ahuja N. Optimizing drug delivery systems using systematic \u201cDesign of experiments\u201d Part I: Fundamental aspects. Crit. Rev. Ther. Drug Carr. Syst. 2005;22:27\u2013105.", "ArticleIdList": ["15715503"]}, {"Citation": "Barmpalexis P., Kanaze F.I., Georgarakis E. Developing and optimizing a validated isocratic reversed-phase high-performance liquid chromatography separation of nimodipine and impurities in tablets using experimental design methodology. J. Pharm. Biomed. Anal. 2009;49:1192\u20131202.", "ArticleIdList": ["19369025"]}, {"Citation": "Sahu P.K., Ramisetti N.R., Cecchi T., Swain S., Patro C.S., Panda J. An overview of experimental designs in HPLC method development and validation. J. Pharm. Biomed. Anal. 2018;147:590\u2013611.", "ArticleIdList": ["28579052"]}, {"Citation": "Lewis G.A., Mathieu D., Phan-Tan-Luu R. Pharmaceutical Experimental Design. CRC Press; Boca Raton, FL, USA: 1998."}, {"Citation": "Heyden Y.V., Massart D. Review of the use of robustness and ruggedness in analytical chemistry. Data Handl. Sci. Technol. 1996;19:79\u2013147."}, {"Citation": "Montgomery D.C. Design and Analysis of Experiments. John Wiley & Sons; Hoboken, NJ, USA: 2017."}, {"Citation": "Dejaegher B., Heyden Y.V. The use of experimental design in separation science. Acta Chromatogr. 2009;21:161\u2013201."}, {"Citation": "Vander Heyden Y., Perrin C., Massart D. Handbook of Analytical Separations. Elsevier; Amsterdam, The Netherlands: 2000. Optimization strategies for HPLC and CZE; pp. 163\u2013212."}, {"Citation": "Dejaegher B., Heyden Y.V. Ruggedness and robustness testing. J. Chromatogr. A. 2007;1158:138\u2013157.", "ArticleIdList": ["17379230"]}, {"Citation": "Dejaegher B., Heyden Y.V. Capillary Electrophoresis Methods for Pharmaceutical Analysis. Elsevier; New York, Amsterdam, The Netherlands: 2008. Robustness testing of CE methods."}, {"Citation": "Candioti L.V., Zan M.M.D., C\u00e1mara M.S., Goicoechea H.C. Experimental design and multiple response optimization. Using the desirability function in analytical methods development. Talanta. 2014;124:123\u2013138.", "ArticleIdList": ["24767454"]}, {"Citation": "Politis N.S., Colombo P., Colombo G., Rekkas D.M. Design of experiments (DoE) in pharmaceutical development. Drug Dev. Ind. Pharm. 2017;43:889\u2013901.", "ArticleIdList": ["28166428"]}, {"Citation": "Borman P., Chatfield M., Jackson P., Laures A., Okafo G. Reduced method robustness testing of analytical methods driven by a risk-based approach. Pharm. Technol. Eur. 2010;22:72\u201379."}, {"Citation": "Plackett R.L., Burman J.P. The design of optimum multifactorial experiments. Biometrika. 1946;33:305\u2013325."}, {"Citation": "Vanaja K., Shobha Rani R. Design of experiments: Concept and applications of Plackett Burman design. Clin. Res. Regul. Aff. 2007;24:1\u201323."}, {"Citation": "Deming S., Morgan S. Handbook of Chemometrics and Qualimetrics: Part A. Technometrics. 1998;40:264."}, {"Citation": "Chowdary K., Shankar K.R. Optimization of pharmaceutical product formulation by factorial designs: Case studies. J. Pharm. Res. 2016;15:105\u2013109."}, {"Citation": "Bezerra M.A., Santelli R.E., Oliveira E.P., Villar L.S., Escaleira L.A. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta. 2008;76:965\u2013977.", "ArticleIdList": ["18761143"]}, {"Citation": "Karna S.K., Sahai R. An overview on Taguchi method. Int. J. Eng. Math. Sci. 2012;1:1\u20137."}, {"Citation": "Box G., Behnken D. Simplex-sum designs: A class of second order rotatable designs derivable from those of first order. Ann. Math. Stat. 1960;31:838\u2013864."}, {"Citation": "Ferreira S.C., Bruns R.E., Ferreira H.S., Matos G.D., David J.M., Brandao G.C., Silva E.G.P., Portugal L.A., Reis P.S., Souza A.S., et al. Box-Behnken design: An alternative for the optimization of analytical methods. Anal. Chim. Acta. 2007;597:179\u2013186.", "ArticleIdList": ["17683728"]}, {"Citation": "Eriksson L., Johansson E., Kettaneh-Wold N., Wikstrom C., Wold S. Design of Experiments: Principles and Applications. Umetrics Academy; Stockholm, Sweden: 2000."}, {"Citation": "Mohini B., Sanju N. Analytical quality by design (AQBD): New paradigm for analytical method development. Int. J. Dev. Res. 2015;5:3589\u20133599."}, {"Citation": "Verch T., Campa C., Chery C., Fenkel R., Graul T., Jaya N., Nakhle B., Springall J., Starkey J., Wypych J., et al. Analytical Quality by Design, Life Cycle Management, and Method Control. AAPS J. 2022;24:34. doi: 10.1208/s12248-022-00685-2.", "ArticleIdList": ["10.1208/s12248-022-00685-2", "35149913"]}, {"Citation": "Arce M., Sanllorente S., Sanchez M.S., Sarabia L.A., Ortiz M.C. Method operable design region obtained with a partial least squares model inversion in the determination of ten polycyclic aromatic hydrocarbons by liquid chromatography with fluorescence detection. J. Chromatogr. A. 2021;1657:462577.", "ArticleIdList": ["34619564"]}, {"Citation": "European Medicines Agency  ICH Guideline Q2(R2) on Validation of Analytical Procedures. Amsterdam, The Netherlands. 2022.  [(accessed on 31 March 2022)].  Available online:  https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-q2r2-validation-analytical-procedures-step-2b_en.pdf."}, {"Citation": "European Medicines Agency  ICH Guideline Q12 on Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management. Amsterdam, The Netherlands. 2020.  [(accessed on 4 March 2020)].  Available online:  https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-q12-technical-regulatory-considerations-pharmaceutical-product-lifecycle-management_en.pdf."}, {"Citation": "Reid G.L., Cheng G., Fortin D.T., Harwood J.W., Morgado J.E., Wang J., Xue G. Reversed-phase liquid chromatographic method development in an analytical quality by design framework. J. Liq. Chromatogr. Relat. Technol. 2013;36:2612\u20132638."}, {"Citation": "Sumithra M., Ravichandiran V., Shanmugasundarm P. AQbD Oriented New LC-ESI/MS Method for Quantification of Sirolimus in Drug and Spiked Plasma Sample. Curr. Anal. Chem. 2018;14:519\u2013529."}, {"Citation": "Staji\u0107 A., Maksi\u0107 J., Maksi\u0107 \u0110., Forsdahl G., Medenica M., Jan\u010di\u0107-Stojanovi\u0107 B. Analytical Quality by Design-based development and validation of ultra pressure liquid chromatography/MS/MS method for glycopeptide antibiotics determination in human plasma. Bioanalysis. 2018;10:1861\u20131876. doi: 10.4155/bio-2018-0181.", "ArticleIdList": ["10.4155/bio-2018-0181", "30412677"]}, {"Citation": "Van Tricht E., Geurink L., Backus H., Germano M., Somsen G.W., Griend C.E.S. One single, fast and robust capillary electrophoresis method for the direct quantification of intact adenovirus particles in upstream and downstream processing samples. Talanta. 2017;166:8\u201314. doi: 10.1016/j.talanta.2017.01.013.", "ArticleIdList": ["10.1016/j.talanta.2017.01.013", "28213262"]}, {"Citation": "Krait S., Dou\u0161a M., Scriba G.K. Quality by design-guided development of a capillary electrophoresis method for the chiral purity determination of ambrisentan. Chromatographia. 2016;79:1343\u20131350. doi: 10.1007/s10337-016-3137-6.", "ArticleIdList": ["10.1007/s10337-016-3137-6"]}, {"Citation": "Perovani I.S., Serpellone C.O., de Oliveira A.R.M. An appraisal of experimental designs: Application to enantioselective capillary electromigration techniques. Electrophoresis. 2021;42:1726\u20131743. doi: 10.1002/elps.202000334.", "ArticleIdList": ["10.1002/elps.202000334", "33544902"]}, {"Citation": "Aboushady D., Hanafi R.S., Parr M.K. Quality by design approach for enantioseparation of terbutaline and its sulfate conjugate metabolite for bioanalytical application using supercritical fluid chromatography. J. Chromatogr. A. 2022;1676:463285. doi: 10.1016/j.chroma.2022.463285.", "ArticleIdList": ["10.1016/j.chroma.2022.463285", "35802964"]}, {"Citation": "Muteki K., Morgado J.E., Reid G.L., Wang J., Xue G., Riley F.W., Harwood J.W., Fortin D.T., Miller I.J. Quantitative structure retention relationship models in an analytical quality by design framework: Simultaneously accounting for compound properties, mobile-phase conditions, and stationary-phase properties. Ind. Eng. Chem. Res. 2013;52:12269\u201312284. doi: 10.1021/ie303459a.", "ArticleIdList": ["10.1021/ie303459a"]}, {"Citation": "Freitas J., Silva P., Vaz-Pires P., C\u00e2mara J.S. A systematic AQbD approach for optimization of the most influential experimental parameters on analysis of fish spoilage-related volatile amines. Foods. 2020;9:1321. doi: 10.3390/foods9091321.", "ArticleIdList": ["10.3390/foods9091321", "PMC7555788", "32961697"]}, {"Citation": "Robu S., Romila A., Buzia O.D., Spac A.F., Diaconu C., Tutunaru D., Lisa E., Nechita A. Contribution to the optimization of a gas chromatographic method by QbD approach used for analysis of essential oils from salvia officinalis. Management. 2019;23:24. doi: 10.37358/RC.19.6.7266.", "ArticleIdList": ["10.37358/RC.19.6.7266"]}, {"Citation": "Vogt F.G., Kord A.S. Development of quality-by-design analytical methods. J. Pharm. Sci. 2011;100:797\u2013812. doi: 10.1002/jps.22325.", "ArticleIdList": ["10.1002/jps.22325", "21280050"]}, {"Citation": "Kim M.-K., Park G., Ji Y., Lee Y.G., Choi M., Go S.H., Son M., Jang Y.P. Design of Experiments-Based Optimization of Flavonoids Extraction from Daphne genkwa Flower Buds and Flavonoids Contents at Different Blooming Stages. Plants. 2022;11:925.", "ArticleIdList": ["PMC9002897", "35406905"]}, {"Citation": "Tefas L.R., Toma I., Tomu\u021b\u0103 I. Quality by Design Approach for the Development of Salinomycin and Gemcitabine Combination Therapy Liposomes for Colorectal Cancer. Farmacia. 2022;70:596\u2013606."}, {"Citation": "Mittal S., Ali J., Baboota S. DoE engineered Development and Validation of an RP-HPLC Method for Simultaneous Estimation of Temozolomide and Resveratrol in Nanostructured Lipid Carrier. J. AOAC Int. 2022;105:1258\u20131267. doi: 10.1093/jaoacint/qsac045.", "ArticleIdList": ["10.1093/jaoacint/qsac045", "35441690"]}, {"Citation": "Gundecha S., Patel M., Mayur Y. An Application of Quality by Design and Analytical Greenness Assessment Approach for the Development of Erlotinib Stability Indicating Method. Chromatographia. 2022;85:575\u2013588. doi: 10.1007/s10337-022-04167-7.", "ArticleIdList": ["10.1007/s10337-022-04167-7"]}, {"Citation": "Muchakayala S.K., Katari N.K., Saripella K.K., Schaaf H., Marisetti V.M., Ettaboina S.K., Rekulapally V.K. Implementation of analytical quality by design and green chemistry principles to develop an ultra-high performance liquid chromatography method for the determination of Fluocinolone Acetonide impurities from its drug substance and topical oil formulations. J. Chromatogr. A. 2022;1679:463380. doi: 10.1016/j.chroma.2022.463380.", "ArticleIdList": ["10.1016/j.chroma.2022.463380", "35970050"]}, {"Citation": "Yabr\u00e9 M., Ferey L., Som\u00e9 T.I., Sivadier G., Gaudin K. Development of a green HPLC method for the analysis of artesunate and amodiaquine impurities using Quality by Design. J. Pharm. Biomed. Anal. 2020;190:113507. doi: 10.1016/j.jpba.2020.113507.", "ArticleIdList": ["10.1016/j.jpba.2020.113507", "32846400"]}, {"Citation": "Kova\u010d L., \u010casar Z., Lu\u0161in T.T., Ro\u0161kar R. Development of an Analytical Method for Determination of Related Substances and Degradation Products of Cabotegravir Using Analytical Quality by Design Principles. ACS Omega. 2022;7:8896\u20138905.", "ArticleIdList": ["PMC8928553", "35309479"]}, {"Citation": "Zagalo D.M., Silva B.M.A., Silva C., Sim\u00f5es S., Sousa J.J. A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: A systematic review. J. Drug Deliv. Sci. Technol. 2022;70:103207. doi: 10.1016/j.jddst.2022.103207.", "ArticleIdList": ["10.1016/j.jddst.2022.103207"]}, {"Citation": "Lee S.L. The Science and Regulations of Naturally Derived Complex Drugs. Springer; Cham, Switzerland: 2019. A Totality-of-evidence approach to ensuring therapeutic consistency of naturally derived complex mixtures; pp. 265\u2013270."}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "28"}, {"Year": "2022", "Month": "10", "Day": "25"}, {"Year": "2022", "Month": "10", "Day": "25"}, {"Year": "2022", "Month": "11", "Day": "11", "Hour": "1", "Minute": "49"}, {"Year": "2022", "Month": "11", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "11", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["36365413", "PMC9653622", "10.3390/plants11212960", "plants11212960"]}}], "PubmedBookArticle": []}